Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

The use of antilymphocyte antibodies for induction therapy or for treatment for rejection has been associated with an increased risk of posttransplant lymphoproliferative disorder (PTLD). The authors investigated the incidence of PTLD after monoclonal antilymphocyte, polyclonal antilymphocyte, inter...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2003-11, Vol.76 (9), p.1289-1293
Hauptverfasser:	CHERIKH, Wida S, KAUFFMAN, H. M, MCBRIDE, Maureen A, MAGHIRANG, Jude, SWINNEN, Lode J, HANTO, Douglas W
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antilymphocyte Serum - therapeutic use Biological and medical sciences Child Cyclosporine - therapeutic use Female Graft Rejection - epidemiology Graft Survival - drug effects Graft Survival - physiology Hematologic and hematopoietic diseases Histocompatibility Testing Humans Immunosuppression - methods Immunosuppressive Agents - therapeutic use Incidence Interleukin-2 - therapeutic use Kidney Transplantation - adverse effects Kidney Transplantation - immunology Kidney Transplantation - mortality Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoproliferative Disorders - epidemiology Male Medical sciences Middle Aged Multivariate Analysis Postoperative Complications - immunology Survival Analysis Tacrolimus - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!